In this Assignment, you will become the “captain of the ship

In this Assignment, you will become the “captain of the ship” as you provide treatment recommendations and identify medical management, community support resources, and follow-up plans for a client with a depression disorder. Learning Objectives Students will: Recommend psychopharmacologic treatments based on   therapeutic endpoints for clients with depression disorders Recommend psychotherapy based on therapeutic endpoints      for clients with depression disorders Identify medical management needs for clients with      depression disorders Identify community support resources for clients with      depression disorders Recommend follow-up plans for clients with depression      disorders To prepare for this Assignment: Select an adult or older adult client with a depressive      disorder you have seen in your      practicum. In 3–4 pages, write a treatment plan for your client in which you do the following: Describe the HPI and clinical impression for the      client. Recommend psychopharmacologic treatments and describe      specific and therapeutic endpoints for your psychopharmacologic agent.      (This should relate to HPI and clinical impression.) Recommend psychotherapy choices (individual, family,      and group) and specific therapeutic endpoints for your choices. Identify medical management needs, including primary      care needs, specific to this client. Identify community support resources (housing,      socioeconomic needs, etc.) and community agencies that are available to      assist the client. Recommend a plan for follow-up intensity and frequency      and collaboration with other providers. Required Readings Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer. · Chapter 8, “Mood Disorders” (pp. 347–386) Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications. · Chapter 12, “Psychotherapy of Mood Disorders” · Chapter 14, “Pharmacological and Somatic Treatments for Major Depressive Disorder” American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. · “Depressive Disorders” · Major Depressive Disorder · Persistent Depressive Disorder (dysthymia) · Premenstrual Dysphoric Disorder · Substance/Medication-Induced Depressive Disorder · Depressive Disorder Due to Another Medical Condition · Other Specified Depressive Disorder · Unspecified Depressive Disorder Stahl, S. M. (2017). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press.   Grieve, S. M., Korgaonkar, M. S., Koslow, S. H., Gordon, E., Williams, L. M. (2013). Widespread reductions in gray matter volume in depression. NeuroImage: Clinical, 3, 332-339. doi:10.1016/j.nicl.2013.08.016 Lach, H. W., Chang, Y-P., & Edwards, D. (2010). Can older adults with dementia accurately report depression using brief forms? Reliability and validity of the Geriatric Depression Scale. Journal of Gerontological Nursing, 36(5), 30–37. doi:10.3928/00989134-20100303-01 Steffens, D. C., McQuoid, D. R., & Potter, G. G. (2014). Amnestic mild cognitive impairment and incident dementia and Alzheimer’s disease in geriatric depression. International Psychogeriatrics, 26(12), 2029–2036. doi:10.1017/S1041610214001446 Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from https://www.dea.gov/druginfo/ds.shtml  Required Media Classroom Productions (Producer). (2015). Depressive Disorders [Video file]. San Luis Obispo, CA: Microtraining Associates.